Intrathecal baclofen withdrawal simulating neuroleptic malignant syndrome in a child with cerebral palsy

Developmental Medicine and Child Neurology

Volumn 42, Issue 8, 2000, Pages 561-565

  Samson Fang, Lisa ^a   Gooch, Judith ^b   Norlin, Chuck ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN;

ARTICLE; CASE REPORT; CEREBRAL PALSY; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG WITHDRAWAL; HUMAN; MALE; NEUROLEPTIC MALIGNANT SYNDROME; PRIORITY JOURNAL; RHABDOMYOLYSIS; SCHOOL CHILD;

BACLOFEN; CEREBRAL PALSY; CHILD; DIAGNOSIS, DIFFERENTIAL; HUMANS; INJECTIONS, SPINAL; MALE; MUSCLE RELAXANTS, CENTRAL; NEUROLEPTIC MALIGNANT SYNDROME; QUADRIPLEGIA; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0033853308     PISSN: 00121622     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0012162200001055     Document Type: Article

References (38)

1. Abel NA, Smith RA. (1994) Intrathecal baclofen for treatment of intractable spinal spasticity. Archives of Physical Medicine and Rehabilitation 75: 54-8.
2. Albright AL, Barron WB, Fasick MR, Polinko P, Janosky J. (1993) Continuous intrathecal baclofen infusion for spasticity of cerebral origin. Journal of the American Medical Association 270: 2475-7.
3. _ Barry MJ, Fasick MP, Janosky J. (1995) Effects of continuous intrathecal baclofen infusion and selective posterior rhizotomy on upper extremity spasticity. Pediatric Neurosurgery 23: 82-5.
4. Armstrong RW, Steinbok P, Farrell K, Cochrane D, Norman MG, Kube S. (1992) Continuous intrathecal baclofen treatment of severe spasms in two children with spinal-cord injury. Developmental Medicine & Child Neurology 34: 731-8.
5. _ Cochrane DD, Kube SD, Fife SE, Farrell K. (1997) Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin. Journal of Neurosurgery 87: 409-14.
6. Azouvi P, Mane M, Thiebaut JB, Denys P, Remy-Neris O, Bussel B. (1996) Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up. Archives of Physical Medicine and Rehabilitation 77: 35-9.
7. Becker R, Alberti O, Bauer BL. (1997) Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain injury. Journal of Neurology 244: 160-6.
8. Brumback RA, Feeback DL, Leech RW. (1992) Rhabdomyolysis in childhood. Pediatric Clinics of North America 39: 821-48.
9. Caroff SN, Mann SC. (1993) Neuroleptic malignant syndrome. Medical Clinics of North America 77: 185-202.
10. Coffey RJ, Cahill D, Steers W, Parks TS, Ordia J, Meythaler JM, Herman R, Shetter AG, Levy R, Gill B. et al. (1993) Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. Journal of Neurosurgery 78: 226-32.
11. Demirkiran M, Jankovic J, Dean JM. (1996) Ecstasy intoxication: an overlap between serotonin syndrome and neuroleptic malignant syndrome. Clinical Neuropharmacology 19: 157-64.
12. Duras M, Kakkouras L, Tuchman AJ, Koppel BS. (1995) Rhabdomyolysis and hyperthermia after cocaine abuse: a variant of the neuroleptic malignant syndrome Acta Neurological Scandinavica 92: 161-5.
13. Fishman RA. (1992) Cerebrospinal Fluid in Diseases of the Nervous System. Philadelphia: WB Saunders Company.
14. Gerszten PC, Albright AL, Barry MJ. (1997) Effect of ambulation of continuous intrathecal baclofen infusion. Pediatric Neurosurgery 27: 40-4.
15. _ Johnstone GF. (1998) Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy. Journal of Neurosurgery 88: 1009-13.
16. Khorasani A, Peruzzin WT. (1995) Dantrolene treatment for abrupt intrathecal baclofen withdrawal. Anesthesia and Analgesia 80: 1054-6.
17. Kroin JS, Bianchi GD, Penn RD. (1993) Intrathecal baclofen down-regulates GABAB receptors in the rat substantia gelatinosa. Journal of Neurosurgery 79: 544-9.
18. Lew TY, Tollefson G. (1983) Chlorpromazine-induced neuroleptic malignant syndrome and its response to diazepam. Biological Psychiatry 18: 1441-6.
19. Lewis KS, Mueller WM. (1993) Intrathecal baclofen for severe spasticity secondary to spinal cord injury. Annals of Pharmacotherapy 27: 767-73.
20. Mandac BR, Hurvitz EA, Nelson VS. (1993) Hyperthermia associated with baclofen withdrawal and increased spasticity. Archives of Physical Medicine and Rehabilitation 74: 96-7.
21. Meythaler JM, Steers W, Tuel SM, Cross LL, Haworth CS. (1992) Continuous intrathecal baclofen in spinal cord spasticity. A prospective study American Journal of Physical Medicine and Rehabilitation 71: 321-7.
22. _ McCary A, Hadley MN. (1997) Prospective assessment of continuous intrathecal infusion of baclofen for spasticity caused by acquired brain injury: a preliminary report. Journal of Neurosurgery 87: 415-9.
23. Middel B, Kuipers-Upmeijer H, Blouma J, Staal M, Postma T, Terpstra S, Stewart R. (1997) Effect of intrathecal baclofen delivered by implanted programmable pump on health related quality of life in patients with severe spasticity. Journal of Neurology, Neurosurgery and Psychiatry 63: 204-9.
24. Muller H (1992) Treatment of severe spasticity: results of a multicenter trial conducted in Germany involving the intrathecal infusion of baclofen by an implantable drug delivery system. Developmental Medicine & Child Neurology 34: 739-45.
25. Nisijima K, Ishiguro T. (1995) Cerebrospinal fluid levels of monoamine metabolites and gamma-aminobutyric acid in neuroleptic malignant syndrome. Journal of Psychiatric Research 29: 233-44.
26. Patterson V, Watt M, Byrnes D, Crowe D, Lee A. (1994) Management of severe spasticity with intrathecal baclofen delivered by a manually operated pump. Journal of Neurology, Neurosurgery and Psychiatry 57: 582-5.
27. Penn RD. (1992) Intrathecal Baclofen for spasticity of spinal origin: seven years of experience. Journal of Neurosurgery 77: 236-40.
28. _ Kroin JS. (1984) Intrathecal baclofen alleviates spinal cord spasticity. Lancet 1: 1078 (Letter.)
29. Reeves RK, Stop-Smith KA, Christopherson MW. (1998) Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter failure. Archives of Physical Medicine and Rehabilitation 79: 353-6.
30. Rifici C, Kofler M, Kronenberg M, Kofler A, Bramanti P, Saltuari L. (1994) Intrathecal baclofen application in patients with supraspinal spasticity secondary to severe traumatic brain injury. Functional Neurology 9: 29-34.
31. Sakkas P, Davis JM, Hua J, Wang Z. (1991) Pharmacotherapy of neuroleptic malignant syndrome Psychiatric Annals 21: 157-64.
32. Sampathkumar P, Scanlon PD, Plevak DJ. (1998) Baclofen withdrawal presenting as multiorgan system failure. Anesthesia and Analgesia 87: 562-3.
33. Sancibrian M, Serrano JS, Minano FJ. (1991)Opioid and prostaglandin mechanisms involved in the effect of GABAergic drugs on body temperature. General Pharmacology 22: 259-62.
34. Schurch B. (1993) Errors and limitations of the multimodality checking methods of defective spinal intrathecal pump systems. Case report. Paraplegia 31: 611-5.
35. Siegfried RN, Jacobson I., Chabal C. (1992) Development of acute withdrawal syndrome following cessation of intrathecal baclofen in a patient with spasticity. Anesthesiology 77: 1048-50.
36. Teddy P, Jamous A, Gardner B, Wang D, Silver J. (1992) Complications of intrathecal baclofen delivery. British Journal of Neurosurgery 6: 115-8.
37. Thomas P, Maron M, Rascle C, Cottencin O, Vaiva G, Goudemand M. (1998) Carbamazepine in the treatment of neuroleptic malignant syndrome. Biological Psychiatry 43: 303-5.
38. Velamoor VR, Norman RMG, Caroff SN, Mann SC, Sullivan KA, Antelo RE. (1994) Progression of symptoms in neuroleptic malignant syndrome. Journal of Nervous and Mental Disease 182:168-73.